Literature DB >> 2832311

Induction of a beta-1,3-D-glucan receptor in P388D1 cells treated with retinoic acid or 1,25-dihydroxyvitamin D3.

R Goldman1.   

Abstract

Retinoic acid (RA) and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) induce the capability to phagocytose heat-killed yeast (Y) (Saccharomyces cerevisiae) in P388D1 cells. Y phagocytosis is specifically inhibited (100%) by particulate and soluble beta-1,3-D-glucan. Other polysaccharides, such as agarose, dextran and dextran sulphate, are not inhibitory. The inhibitory capacity of mannan was totally abrogated by treatment with beta-glucanase, suggesting that its activity is derived from a residual beta-glucan structure. Partial hydrolysis of glucan particles with formic acid yielded soluble glucan that was fractionated according to size. Glucan1, glucan2 and glucan3 had an average chain length of 34, 23.5 and 15.5 glucose units, respectively. Fifty percent inhibition of Y phagocytosis by RA-P388D1 cells was attained at less than 0.02 microgram/ml (approximately 2 nM) glucan1 and at 1.1 micrograms/ml glucan3. A further decrease in chain length (less than or equal to 12.6) resulted in oligomers of marginal inhibitory activity. Preincubation of RA- and 1,25(OH)2D3-P388D1 cells with glucan1 for 30 seconds to 5 min, at 4 degrees or 37 degrees, followed by washes with buffer, sufficed to bring about 85-95% inhibition of Y phagocytosis. Recovery of the phagocytic capability was time dependent and required protein synthesis, suggesting a glucan1-induced removal of membrane receptors. The results suggest that recognition and ingestion of Y by RA- or 1,25(OH)2D3-treated P388D1 cells depends almost exclusively on a beta-glucan-specific receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832311      PMCID: PMC1454530     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  On the composition of zymosan.

Authors:  F J DI CARLO; J V FIORE
Journal:  Science       Date:  1958-04-04       Impact factor: 47.728

2.  The cytotoxic effect of mouse macrophages stimulated in vitro by a beta-1,3-D-glucan from yeast cell walls.

Authors:  J Bögwald; E Johnson; R Seljelid
Journal:  Scand J Immunol       Date:  1982-03       Impact factor: 3.487

3.  Antitumor activity of degraded products of lentinan: its correlation with molecular weight.

Authors:  T Sasaki; N Takasuka; G Chihara; Y Y Maeda
Journal:  Gan       Date:  1976-04

4.  Characterization of the mannose/fucose receptor on human mononuclear phagocytes.

Authors:  V L Shepherd; E J Campbell; R M Senior; P D Stahl
Journal:  J Reticuloendothel Soc       Date:  1982-12

5.  Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosomal enzyme release.

Authors:  B Zimmer; H P Hartung; G Scharfenberger; D Bitter-Suermann; U Hadding
Journal:  Eur J Immunol       Date:  1982-05       Impact factor: 5.532

6.  Induction of a high phagocytic capability in P388D1, a macrophage-like tumor cell line, by 1 alpha, 25-dihydroxyvitamin D3.

Authors:  R Goldman
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

7.  Complement (C3) receptor-mediated attachment of agarose beads to mouse peritoneal macrophages and human monocytes.

Authors:  E Johnson; J Bøgwald; T Eskeland; R Seljelid
Journal:  Scand J Immunol       Date:  1983-05       Impact factor: 3.487

8.  Expression of a mannosyl-fucosyl receptor for endocytosis on cultured primary macrophages and their hybrids.

Authors:  P Stahl; S Gordon
Journal:  J Cell Biol       Date:  1982-04       Impact factor: 10.539

9.  Yeast mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophages.

Authors:  S S Sung; R S Nelson; S C Silverstein
Journal:  J Cell Biol       Date:  1983-01       Impact factor: 10.539

10.  Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan.

Authors:  R A Ezekowitz; R B Sim; M Hill; S Gordon
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

View more
  3 in total

1.  Beneficial effect of enhanced macrophage function in the trauma patient.

Authors:  W Browder; D Williams; H Pretus; G Olivero; F Enrichens; P Mao; A Franchello
Journal:  Ann Surg       Date:  1990-05       Impact factor: 12.969

Review 2.  CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions.

Authors:  G D Ross; V Vĕtvicka
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

3.  Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form.

Authors:  C E Cross; G J Bancroft
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.